BrainNow Research Institute, Shenzhen, Guangdong Province, China.
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
BMC Med Imaging. 2022 Jul 4;22(1):117. doi: 10.1186/s12880-022-00841-2.
Automated brain volumetry has been widely used to assess brain volumetric changes that may indicate clinical states and progression. Among the tools that implement automated brain volumetry, AccuBrain has been validated for its accuracy, reliability and clinical applications for the older version (IV1.2). Here, we aim to investigate the performance of an updated version (IV2.0) of AccuBrain for future use from several aspects.
Public datasets with 3D T1-weighted scans were included for version comparisons, each with Alzheimer's disease (AD) patients and normal control (NC) subjects that were matched in age and gender. For the comparisons of the brain volumetric measures quantified from the same scans, we investigated the difference of hippocampal segmentation accuracy (using Dice similarity coefficient [DSC] as the major measurement). As AccuBrain generates a composite index (AD resemblance atrophy index, AD-RAI) that indicates similarity with AD-like brain atrophy pattern, we also compared the two versions for the diagnostic accuracy of AD versus NC with AD-RAI. Also, we examined the intra-scanner reproducibility of the two versions for the scans acquired with short-intervals using intraclass correlation coefficient.
AccuBrain IV2.0 presented significantly higher accuracy of hippocampal segmentation (DSC: 0.91 vs. 0.89, p < 0.001) and diagnostic accuracy of AD (AUC: 0.977 vs. 0.921, p < 0.001) than IV1.2. The results of intra-scanner reproducibility did not favor one version over the other.
AccuBrain IV2.0 presented better segmentation accuracy and diagnostic accuracy of AD, and similar intra-scanner reproducibility compared with IV1.2. Both versions should be feasible for use due to the small magnitude of differences.
自动化脑容量测量已广泛用于评估可能表明临床状态和进展的脑容量变化。在实施自动化脑容量测量的工具中,AccuBrain 因其准确性、可靠性和对旧版本(IV1.2)的临床应用而得到验证。在这里,我们旨在从多个方面研究 AccuBrain 更新版本(IV2.0)的性能,以便将来使用。
纳入了具有 3D T1 加权扫描的公共数据集进行版本比较,每个数据集都包含年龄和性别匹配的阿尔茨海默病(AD)患者和正常对照(NC)受试者。对于从相同扫描中量化的脑容量测量的比较,我们研究了海马分割准确性的差异(使用 Dice 相似系数[DSC]作为主要测量指标)。由于 AccuBrain 生成了一个复合指数(AD 相似性萎缩指数,AD-RAI),表明与 AD 样脑萎缩模式的相似性,我们还比较了这两个版本对 AD 与 NC 的诊断准确性,使用 AD-RAI。此外,我们使用内类相关系数检查了两个版本在短时间间隔内采集的扫描的内扫描可重复性。
AccuBrain IV2.0 呈现出明显更高的海马分割准确性(DSC:0.91 与 0.89,p<0.001)和 AD 的诊断准确性(AUC:0.977 与 0.921,p<0.001)。内扫描可重复性的结果不支持一个版本优于另一个版本。
与 IV1.2 相比,AccuBrain IV2.0 具有更好的分割准确性和 AD 的诊断准确性,并且内扫描可重复性相似。由于差异幅度较小,两个版本都应该可行。